Reuters logo
BRIEF-Mannkind Corp says FDA updates Afrezza prescribing information
2017年10月2日 / 上午10点20分 / 17 天前

BRIEF-Mannkind Corp says FDA updates Afrezza prescribing information

Oct 2 (Reuters) - Mannkind Corp:

* FDA updates Afrezza® prescribing information

* Says ‍U.S. FDA has approved an update to Afrezza prescribing information​

* Mannkind Corp - ‍U.S. FDA has approved an update to Afrezza prescribing information to include new clinical data​

* Says ‍label update includes study data that describe time-action profile by dosage strength​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below